Biochemical markers in the assessment of bone disease.
As the mean age of our population increases, increasing attention has been paid to the diseases associated with aging, including diseases of the skeleton such as osteoporosis. Effective means of treating and possibly preventing such skeletal disorders are emerging, making their early recognition an important goal for the primary care physician. Although bone density measurements and skeletal imaging studies remain of primary diagnostic importance in this regard, a large number of assays for biochemical markers of bone formation and resorption are being developed that promise to complement the densitometry measurements and imaging studies, providing an assessment of the rates of bone turnover and an earlier evaluation of the effects of therapy. In this review, emphasizing the recent literature, the major biochemical markers currently in use or under active investigation are described, and their application in a number of diseases of the skeleton including osteoporosis is evaluated.
Bikle
D D
DD
University of California and Veterans Administration Medical Center, San Francisco 94121, USA.
D015415:Biomarkers / Q000097:blood* / Q000652:urine*; D001847:Bone Diseases / Q000097:blood / Q000191:economics / Q000378:metabolism* / Q000652:urine; D001862:Bone Resorption / Q000378:metabolism; D006801:Humans; D014481:United States
D015415:Biomarkers